A reasonable speculation would be that the TP53 proteins encoded by HBC-variants are still functional but that the variants cause subtle qualitative or quantitative functional changes that alter the transcriptional output in a way that predisposes carriers to breast cancer but not to other LFS phenotypes. This evidence concerns the gene TP53 and breast carcinoma.